Centogene N.V. announced Berndt Modig?s decision to resign from the company?s Supervisory Board, effective August 15, 2023. Mr. Modig?s resignation was not the result of any disagreement with the Company, and was in alignment with his intention announced on November 21, 2022 to transition off the Supervisory Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4889 USD | +1.88% | +7.24% | -59.26% |
Apr. 02 | Centogene Gets Nasdaq Noncompliance Notice | MT |
Mar. 19 | Centogene, Takeda Pharmaceutical Collaborate on Lysosomal Storage Disorders Diagnostics | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.26% | 13.62M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CNTG Stock
- News Centogene N.V.
- Centogene N.V. Announces Resignation of Berndt Modig from Supervisory Board